Mission
TO FUND RESEARCH TO DISCOVER CURES AND MORE EFFECTIVE TREATMENTS FOR NEUROENDOCRINE CANCERS. THE NETRF IS COMMITTED TO IMPROVING THE LIVES OF THOSE AFFECTED BY NEUROENDOCRINE CANCER BY PROVIDING INFORMATION & EDUCATIONAL RESOURCES.
Public Charity
NEUROENDOCRINE TUMOR RESEARCH FOUNDATION
NEUROENDOCRINE TUMOR RESEARCH FOUNDATION is a nonprofit organization categorized as Public Charity based in QUINCY, MA. Its most recent IRS filing (2024) reports revenue of $4.0M, expenses of $3.8M, total assets of $21.4M. Imperigo tracks 70 reported grant relationships connected to this organization totaling approximately $3.8M.
EIN: 201945347
QUINCY, MA
Latest filing: 2024
Total Revenue$4.0M
Total Expenses$3.8M
Total Assets$21.4M
Grant Records70
Funding Total$3.8M
Filing Years2020–2024
Sample Grants Received
For grant recipient's exempt purposes
$357,975
PROVIDE GENERAL OPERATING SUPPORT
$250,000
$131,906
GENERAL SUPPORT
$38,914
Showing up to 5 of 70 total records — full history available with membership.
Officers & Directors
DIRECTOR OF RESEARCH
Anna Greene
DIRECTOR
Anthony Detre
SECRETARY
Brendan Foley Until 62024
DIRECTOR
Carrie Camino As Of 42024
DIRECTOR OF COMMUNICATIONS
Christina Coffey Until 072024
CHIEF EXECUTIVE OFFICER
Elyse Gellerman
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $4.0M | $3.8M | $21.4M |
| 2023 | $3.2M | $3.6M | $20.6M |
| 2022 | $3.1M | $3.5M | $20.5M |
| 2021 | $8.2M | $5.4M | $26.6M |
| 2020 | $4.7M | $4.0M | $23.8M |
Between 2020 and 2024, reported annual revenue declined from $4.7M to $4.0M (-14%), with total assets most recently reported at $21.4M.
Interactive year-over-year charts and full filing details available with membership.